We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Korro Bio Inc (KRRO) USD0.001

Sell:$50.00 Buy:$70.00 Change: $3.40 (6.63%)
Market closed |  Prices as at close on 17 May 2024 | Switch to live prices |
Sell:$50.00
Buy:$70.00
Change: $3.40 (6.63%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 17 May 2024 | Switch to live prices |
Sell:$50.00
Buy:$70.00
Change: $3.40 (6.63%)
Market closed |  Prices as at close on 17 May 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Korro Bio, Inc. is a biopharmaceutical company. The Company discovers, develops, and commercializes genetic medicines based on editing ribonucleic acid (RNA), enabling treatment of both rare and highly prevalent diseases. The Company is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, it is expanding the reach of genetic medicines. Its Oligonucleotide Promoted Editing of RNA (OPERA) is a foundational platform for RNA editing, which is designed to edit RNA in vivo by delivering an oligonucleotide guide that can target specific RNA sequences. The Company’s first development candidate, KRRO-110, is in development as a potential treatment for Alpha-1 Antitrypsin Deficiency (AATD), that has the potential to be disease-modifying and provide a differentiated therapeutic option.

Contact details

Address:
One Kendall Square. Building 600-700
Suite 6-401
CAMBRIDGE
02139
United States
Telephone:
+1 (617) 4681999
Website:
https://www.korrobio.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
KRRO
ISIN:
US5009461089
Market cap:
$489.32 million
Shares in issue:
9.27 million
Sector:
Biotechnology
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Ram Aiyar
    President, Chief Executive Officer, Director
  • Vineet Agarwal
    Chief Financial Officer, Principal Accounting Officer, Treasurer, Principal Financial Officer
  • Todd Chappell
    Chief Operating Officer
  • Shelby Walker
    Senior Vice President, General Counsel, Corporate Secretary
  • Stephanie Engels
    Senior Vice President - People and Culture
  • Venkat Krishnamurthy
    Senior Vice President - Platform
  • Steve Colletti
    Chief Scientific Officer
  • Quentin Mccubbin
    Chief Manufacturing Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.